Acceptance and commitment therapy for the treatment of irritable bowel syndrome and inflammatory bowel disease: a narrative review
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index; none of the 88 sources its claims cite is checked for support yet.
Abstract
Background and Objective: Cognitive behavioral therapy (CBT) is a common treatment modality for patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). CBT may not be a good fit for all patients and some may instead benefit from an acceptance and commitment therapy (ACT) approach. This narrative review presents evidence for the use of ACT in adult patients with IBS or IBD. The authors also suggest instances in which patients with IBS or IBD may benefit from ACT and discuss future directions of research. Methods: Between August 2023 and January 2024, databases such as Google Scholar, institutional libraries, and PubMed were used to review the literature on ACT in patients with IBS and IBD. A variety of search terms were included. Non-English, pediatric, and studies that did not employ a full ACT protocol were excluded. Key Content and Findings: ACT for IBS studies typically utilized a self-help book or a one-day workshop intervention, with results indicating reductions in IBS and mood symptoms and improvements in quality of life. Within IBD, three randomized controlled trials (RCTs) tested the impact of ACT, two of which found reductions in stress, depression, and anxiety symptoms. Conclusions: Despite the limited number of studies testing a full ACT protocol in patient populations with IBS or IBD, results indicate potential efficacy in managing not only symptoms, but also facets of quality of life. Future studies should utilize robust experimental designs and comprehensively test the effectiveness of ACT in IBS and IBD patient populations with both process and outcome measures. © Translational Gastroenterology and Hepatology. All rights reserved.
Verifying this paper
8 of 9 steps done · this page updates itself — you can leave and come back
- Registry recordVerified
- Full textRead the full text
- Reference list49 references found
- Reference checkChecking each cited work — 49 of 49
- StatisticsRecomputed
- Claims60 claims anchored to a quote
- Cited sourcesChecked
- Self-checkChecked
- VerificationFindings verified
Overview
CoChat Summary
## TL;DR
This narrative review concludes that ACT shows promise for adults with IBS and IBD, especially for improving symptoms, quality of life, and psychological distress, but the evidence base is still small and methodologically uneven. The authors argue that future work should use fuller, more rigorous ACT protocols and better test when ACT is preferable to CBT.
## Key findings
- For IBS, the review says the available studies “typically utilized a self-help book or a one-day workshop,” and reported reductions in IBS and mood symptoms plus improvements in quality of life.
- In the main IBS study described, 56 patients with IBS symptoms for the past 12 months were studied; the ACT protocol was associated with increases in acceptance of IBS and QOL, and decreases in IBS symptoms, avoidance, and health anxiety, with effects persisting to 6 months.
- The review states that approximately 20% of patients with IBS did not meet criteria for IBS at the end of that study, and about 35% reported a change in symptom severity.
- For IBD, the paper says only three randomized controlled trials tested ACT; two found reductions in stress, depression, and anxiety, and one ACTforIBD study found lower anxiety and higher psychological flexibility after treatment.
- In the LIFEwithIBD trial, results were not yet published at the time of the review; the authors note that existing IBD studies often have high risk of bias and that one non-RCT study found about 40–58% of participants benefitted in some way.
## Methods
- Narrative review of ACT for adult patients with IBS and IBD, with outcomes framed as GI symptom reduction, quality of life, mood/anxiety changes, or process outcomes such as psychological flexibility.
- Literature was reviewed between August 2023 and January 2024 using Google Scholar, institutional libraries, and PubMed, with a variety of search terms.
- Excluded were non-English studies, pediatric studies, and studies that did not employ a full ACT protocol.
## Limitations
- The paper states there are “limited” studies and “notable gaps” in the literature, including a lack of experimental testing of ACT as a structured protocol and a lack of published results for at least one IBD trial.
- The review notes that many ACT studies used self-guided interventions, which may have drawbacks such as lower adherence, treatment withdrawal, or dropout; this is a limitation of the included evidence, and the text also makes evident that this may weaken causal interpretation.
- The paper states that outcomes were inconsistent across studies and that many IBD studies may have high risk of bias because they may not have tested patients with active IBD symptoms.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
0 Valid · 0 Not valid · 53 Not checked · 7 Own results and interpretations
None of the sources cited for this claim could be matched to a paper, so there is nothing to check it against.
In the paper
“Ongoing symptoms of anxiety and depression in patients with IBS and IBD can significantly impact GI symptoms and treatment course (5,12).”
§ Acceptance and commitment therapy for the treatment of irritable bowel syndrome and inflammatory bowel disease: a narrative review > Introduction > Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD)
What the sources say
- Not matchedcites [5] Staudacher HM Black CJ Teasdale SB Irritable bowel syndrome and mental health comorbidity - approach to multidisciplinary management. Nat Rev Gastroenterol Hepatol 2023; 20: 582- 96. 10.1038/s41575-023-00794-z 37268741 PMC10237074
We don’t have this paper’s reference list.
- Not matchedcites [12] Fairbrass KM Lovatt J Barberio B Bidirectional brain-gut axis effects influence mood and prognosis in IBD: a systematic review and meta-analysis. Gut 2022; 71: 1773- 80. 10.1136/gutjnl-2021-325985 34725197
We don’t have this paper’s reference list.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
None of the sources cited for this claim could be matched to a paper, so there is nothing to check it against.
In the paper
“For GI conditions such as IBS, multiple randomized controlled trials (RCTs) and systematic reviews support the use of CBT for reducing GI symptoms and improving QOL (15,22,23).”
§ Acceptance and commitment therapy for the treatment of irritable bowel syndrome and inflammatory bowel disease: a narrative review > Introduction > Overview of CBT
What the sources say
- Not matchedcites [15] Black CJ Thakur ER Houghton LA Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut 2020; 69: 1441- 51. 10.1136/gutjnl-2020-321191 32276950
We don’t have this paper’s reference list.
- Not matchedcites [22] Everitt HA Landau S O'Reilly G Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial. Lancet Gastroenterol Hepatol 2019; 4: 863- 72. 10.1016/S2468-1253(19)30243-2 31492643 PMC7026694
We don’t have this paper’s reference list.
- Not matchedcites [23] Ford AC Lacy BE Harris LA Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis. Am J Gastroenterol 2019; 114: 21- 39. 10.1038/s41395-018-0222-5 30177784
We don’t have this paper’s reference list.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“Wynne and colleagues (42) compared an eight-week group-based ACT intervention to a treatment as usual group by recruiting individuals with high levels of distress with quiescent or “mildly active” IBD.”
§ Acceptance and commitment therapy for the treatment of irritable bowel syndrome and inflammatory bowel disease: a narrative review > Results > ACT for IBD
What the sources say
- Not matchedcites [42] Wynne B McHugh L Gao W Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel Diseases. Gastroenterology 2019; 156: 935- 945.e1. 10.1053/j.gastro.2018.11.030 30452919
We don’t have this paper’s reference list.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“Stress reductions were also observed via cortisol in hair samples (42).”
§ Acceptance and commitment therapy for the treatment of irritable bowel syndrome and inflammatory bowel disease: a narrative review > Results > ACT for IBD
What the sources say
- Not matchedcites [42] Wynne B McHugh L Gao W Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel Diseases. Gastroenterology 2019; 156: 935- 945.e1. 10.1053/j.gastro.2018.11.030 30452919
We don’t have this paper’s reference list.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“The main study by Dr. Ferreira’s group included 56 patients who had IBS symptoms for the past 12 months without significant improvement in symptoms (38).”
§ Acceptance and commitment therapy for the treatment of irritable bowel syndrome and inflammatory bowel disease: a narrative review > Results > ACT for IBS As of 2020, ACT was rated as having level IV evidence for GI conditions (36). There are a few studies that have looked at the use of ACT for patients with IBS, most of which appear to have been conducted by Dr. Nuno Ferreira’s research group or studies that used aspects of their ACT for IBS protocol (37). The main study by Dr. Ferreira’s group included 56 patients who had IBS symptoms for the past 12 months without significant improvement in symptoms (38). The study assessed for IBS symptoms via the IBS Symptom Severity Scale (IBS-SSS), acceptance of IBS symptoms via the IBS Acceptance and Action Questionnaire (IBS-AAQ), QOL via the IBS Impact on QOL Scale (IBS36S), avoidant coping via the IBS Behavioral Responses Questionnaire (IBS-BRQ), and anxiety/hypervigilance via the Visceral Sensitivity Index (VSI) at the start of the study, pre-treatment, post-treatment, and at a 6 month follow up (38). The ACT for IBS treatment protocol included a one-day six-hour ACT intervention workshop lead by a clinical psychologist and participants used a self-help manual for two months after completing the workshop (37,38). Both the workshop and book covered similar topics including psychoeducation on IBS, mindfulness, and ACT based skills/interventions including mindfulness, defusion, creative hopelessness, values-identification, and values-based action (38). The self-help manual used was called “Better Living with IBS” and is currently published as a book (37). Metaphors and experiential exercises were used in both intervention formats and participants were given an audio recording of ACT exercises to assist with practicing ACT skills. Two follow up phone calls were made to participants by a clinical psychologist to assist participants with the self-help manual (38). The study found increases in acceptance of IBS, QOL, and decreases in IBS symptoms, avoidance, and health anxiety, all of which held at the six-month follow up (38). Approximately 20% of patients with IBS did not meet criteria for IBS at the end of the study and about 35% of patients with IBS reported a change in symptom severity (38), further suggesting that ACT may benefit patients with IBS. In another study, Gillanders and colleagues gave the same ACT book and audio recordings (38) to 45 patients with IBS, though no workshop was included in this study (39). They used the same outcomes measures at the start of the study as Ferreira and colleagues with additional assessments at two months and six months (38,39). Participants were instructed to complete the self-help manual at their own pace but were encouraged to complete the manual within two months (39). Follow up phone calls were made during the first and second month by a research assistant to encourage completion of the book and provide clarification as needed (39). Gillanders and colleagues found a significant improvement in IBS severity, health anxiety, and IBS acceptance (39) but no changes in avoidance behaviors and QOL. The researchers did not assess the number of exercises or the percentage of the self-help manual that was completed, though they hypothesized that participant engagement may have impacted the lack of changes seen in avoidance behaviors and QOL (39). The only RCT on ACT and IBS that could be found assessed IBS symptoms in non-IBS patients, meaning that the patients were not formally diagnosed with IBS but scored high on the IBS Severity Index (Japanese Version) (40). Twenty-six participants were randomized to either the waitlist or the intervention ACT group. Similar domains were assessed compared to previous studies, with avoidance being measured by the AAQ-II, QOL via the Japanese version of the IBS-QOL, HRQoL being measured by the SF-36, depression symptoms were measured by the Beck Depression Inventory-II, anxiety symptoms were measured by the State-Trait Anxiety Inventory, cognitive fusion was measured by the Cognitive Fusion Questionnaire, and mindfulness was assessed through the Japanese version of the Five Facet Mindfulness Questionnaire (40). Assessment measures were completed pre-intervention, post-intervention, and at the two month follow up. The authors used a similar procedure as Ferreira and colleagues [2018] (38) with a 1-day ACT workshop and the use of an ACT self-help manual, though in the current study, they used a different ACT book due to “Better Living with IBS” not being available in Japanese (40). Participants completed 6 adherence quizzes regarding content in the self-help ACT book (40). The study found significant improvements in depression symptoms in the ACT group compared to the waitlist group, but no significant differences were noted in symptom severity and the outcomes of interest (40). The study had low power and the authors noted concerns with internal consistency (40). Similar to Gillanders and colleagues, Ita and Muto hypothesized that participant completion of the ACT manual was not sufficient to see changes in avoidance behaviors and QOL and that participants may have needed additional practice on the behavioral implementation of ACT skills (39,40). The mechanism by which ACT may help patients with IBS may be due to acceptance of symptoms. Bowers and colleagues (41) conducted a secondary data analysis of Gillanders and colleagues (39) and Ferreira and colleagues (38) studies and concluded that IBS acceptance may mediate and moderate IBS QOL. The authors hypothesize that participants with IBS who have more IBS acceptance engage in less avoidant behaviors (i.e., more values-based behavior) and thus see less of an impact on their QOL (41). IBS acceptance may be protective even if symptom severity is high, which is consistent with literature on ACT in other chronic health conditions (41).
What the sources say
- Not matchedcites [38] Ferreira NB Gillanders D Morris PG Pilot study of acceptance and commitment therapy for irritable bowel syndrome: A preliminary analysis of treatment outcomes and processes of change. Clinical Psychologist. 2018; 22: 241- 50. 10.1111/cp.12123
We don’t have this paper’s reference list.
plainn = 56- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
7 more claims
Create a free account to see all 60 claims and every source verdict.
- It may state two separate claims as one. 39
- Probably not a substantial claim. 16
- The quote only partly states this claim. 1
Citations
Cites
Ng, S. C., Shi, H. Y., Hamidi, N., Underwood, F. E., Tang, W., Benchimol, E. I., Panaccione, R., Ghosh, S., Wu, J. C. Y., Chan, F. K. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32448-0 · Cited by 6,087 · cited 1×
“IBD is an organic disease and affects approximately 0.3% of western countries with increasing prevalence (6,7).”
InfluentialBond, F. W., Hayes, S. C., Baer, R. A., Carpenter, K. M., Guenole, N., Orcutt, H. K., Waltz, T., & Zettle, R. D. (2011) · Behavior Therapy · doi:10.1016/j.beth.2011.03.007 · Cited by 3,950
Hayes, S. C., Wilson, K. G., Gifford, E. V., Follette, V. M., & Strosahl, K. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.64.6.1152 · Cited by 3,595
Psychological flexibility as a fundamental aspect of health
Kashdan, T. B., & Rottenberg, J. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.03.001 · Cited by 3,054 · cited 1×
“…via a series of interdependent principles called a hexaflex (29-31) (see Figure 1 ), which center around the construct of psychological flexibility, or the ability to endure and adapt to changes in circumstances and move toward valued actions while remaining focused on the present moment (32).”
Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Rome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction
Drossman, D. A., & Hasler, W. L. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.035 · Cited by 1,928
Hayes, S. C., Levin, M. E., Plumb-Vilardaga, J., Villatte, J. L., & Pistorello, J. (2013) · Behavior Therapy · doi:10.1016/j.beth.2009.08.002 · Cited by 1,120 · cited 2×
“ACT operates via a series of interdependent principles called a hexaflex (29-31) (see Figure 1 ), which center around the construct of psychological flexibility, or the ability to endure and adapt to changes in circumstances and move toward valued actions while remaining focused on the present…”
ACG Clinical Guideline: Management of Irritable Bowel Syndrome
Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001036 · Cited by 893 · cited 1×
“IBS a disorder of brain-gut interaction (1,2) that involves frequent abdominal pain related to either bowel movements themselves or is associated with alterations in the consistency of stool or frequency of bowel movements (2,3).”
Hayes, S. C. (2016) · Behavior Therapy · doi:10.1016/j.beth.2016.11.006 · Cited by 785 · cited 10×
“Unlike CBT, ACT does not focus on questioning and challenging the nature of thoughts (29).”
InfluentialMeyerowitz-Katz, G., Ravi, S., Arnolda, L., Feng, X., Maberly, G., & Astell-Burt, T. (2020) · Journal of Medical Internet Research · doi:10.2196/20283 · Cited by 561 · cited 1×
“While self-guided protocols offer flexibility and convenience for patients, there may also be drawbacks, such as lower adherence, treatment withdrawal, or dropout (56,57).”
Zamani, M., Alizadeh‐Tabari, S., & Zamani, V. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15325 · Cited by 496 · cited 1×
“For example, about 23–33% of patients with IBD also report diagnoses of anxiety and/or depression, with the prevalence of sub-clinical anxiety and depressive symptoms being even higher among these patients (10,11).”
Ford, A. C., Lacy, B. E., Harris, L. A., Quigley, E. M. M., & Moayyedi, P. (2019) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0222-5 · Cited by 467 · cited 1×
“For GI conditions such as IBS, multiple randomized controlled trials (RCTs) and systematic reviews support the use of CBT for reducing GI symptoms and improving QOL (15,22,23).”
Palsson, O. S., Whitehead, W., Törnblom, H., Sperber, A. D., & Simren, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.021 · Cited by 461
Review article: the economic impact of the irritable bowel syndrome
Canavan, C., West, J., & Card, T. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12938 · Cited by 458
Beatty, L., & Binnion, C. (2016) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9556-9 · Cited by 347 · cited 1×
“While self-guided protocols offer flexibility and convenience for patients, there may also be drawbacks, such as lower adherence, treatment withdrawal, or dropout (56,57).”
Black, C. J., Thakur, E. R., Houghton, L. A., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2020) · Gut · doi:10.1136/gutjnl-2020-321191 · Cited by 299 · cited 2×
“Historically, cognitive behavioral therapy (CBT) has been a popular behavioral health treatment modality for patients with IBS (15-17) and IBD (18-20).”
Gaylord, S. A., Palsson, O. S., Garland, E. L., Faurot, K. R., Coble, R. S., Mann, D. J., Frey, W., Leniek, K., & Whitehead, W. E. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.184 · Cited by 281 · cited 1×
“Promisingly, other studies in IBS and IBD have examined components of ACT, like mindfulness (52-55) and found resulting success in reducing stress, improving HRQoL, or in some cases, reducing GI symptoms in these patient populations.”
Fairbrass, K. M., Costantino, S. J., Gracie, D. J., & Ford, A. C. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30300-9 · Cited by 259 · cited 2×
“IBS and IBD commonly co-occur, with about 37% of patients diagnosed with quiescent CD (8) and nearly a third of patients with UC in remission also reporting symptoms of IBS (8,9).”
Irritable bowel syndrome and mental health comorbidity — approach to multidisciplinary management
Staudacher, H. M., Black, C. J., Teasdale, S. B., Mikocka-Walus, A., & Keefer, L. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00794-z · Cited by 249 · cited 1×
“Ongoing symptoms of anxiety and depression in patients with IBS and IBD can significantly impact GI symptoms and treatment course (5,12).”
Fairbrass, K. M., Lovatt, J., Barberio, B., Yuan, Y., Gracie, D. J., & Ford, A. C. (2022) · Gut · doi:10.1136/gutjnl-2021-325985 · Cited by 225 · cited 1×
“Ongoing symptoms of anxiety and depression in patients with IBS and IBD can significantly impact GI symptoms and treatment course (5,12).”
A Rome Working Team Report on Brain-Gut Behavior Therapies for Disorders of Gut-Brain Interaction
Keefer, L., Ballou, S. K., Drossman, D. A., Ringstrom, G., Elsenbruch, S., & Ljótsson, B. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.09.015 · Cited by 213 · cited 1×
“CBT can help with reducing IBS symptoms, decreasing avoidance, and illness specific cognitions (22,24,25).”
Wynne, B., McHugh, L., Gao, W., Keegan, D., Byrne, K., Rowan, C., Hartery, K., Kirschbaum, C., Doherty, G., Cullen, G., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.11.030 · Cited by 188 · cited 5×
“The results showed that stress, perceived stress, and depression scores decreased more significantly in the ACT group at both post-intervention and three-month follow ups as compared to the treatment as usual group (42).”
InfluentialZernicke, K. A., Campbell, T. S., Blustein, P. K., Fung, T. S., Johnson, J. A., Bacon, S. L., & Carlson, L. E. (2013) · International Journal of Behavioral Medicine · doi:10.1007/s12529-012-9241-6 · Cited by 178
A review of AAQ variants and other context-specific measures of psychological flexibility
Ong, C. W., Lee, E. B., Levin, M. E., & Twohig, M. P. (2019) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.02.007 · Cited by 142
Cognitive-behavioral therapy for patients with irritable bowel syndrome: current insights
Kinsinger, S. (2017) · Psychology Research and Behavior Management · doi:10.2147/prbm.s120817 · Cited by 120 · cited 6×
“CBT for GI conditions (IBS and IBD) works by changing disease specific negative automatic thoughts and disease specific avoidance which may reduce physical GI symptoms and enhance one’s QOL (17).”
InfluentialEveritt, H. A., Landau, S., O'Reilly, G., Sibelli, A., Hughes, S., Windgassen, S., Holland, R., Little, P., McCrone, P., Bishop, F. L., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30243-2 · Cited by 116 · cited 2×
“For GI conditions such as IBS, multiple randomized controlled trials (RCTs) and systematic reviews support the use of CBT for reducing GI symptoms and improving QOL (15,22,23).”
Knowles, S. R., Monshat, K., & Castle, D. J. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318296ae5a · Cited by 102 · cited 2×
“Historically, cognitive behavioral therapy (CBT) has been a popular behavioral health treatment modality for patients with IBS (15-17) and IBD (18-20).”
McCombie, A., Gearry, R., Andrews, J., Mulder, R., & Mikocka-Walus, A. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000567 · Cited by 100 · cited 1×
“Though there is more evidence for CBT helping to decrease IBS symptoms, it is possible that CBT could also help with improving IBD symptoms, coping (18,19), health-related QOL [HRQoL; (26,27)], symptoms of depression or anxiety (18,26), catastrophizing (26), and visceral sensitivity (26).”
Ewais, T., Begun, J., Kenny, M., Rickett, K., Hay, K., Ajilchi, B., & Kisely, S. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2018.11.010 · Cited by 89
Riggott, C., Mikocka-Walus, A., Gracie, D. J., & Ford, A. C. (2023) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(23)00186-3 · Cited by 83 · cited 3×
“Historically, cognitive behavioral therapy (CBT) has been a popular behavioral health treatment modality for patients with IBS (15-17) and IBD (18-20).”
Henriksen, M., Høivik, M. L., Jelsness‐Jørgensen, L., Moum, B. A., & IBSEN Study Group (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx152 · Cited by 80 · cited 2×
“IBS and IBD commonly co-occur, with about 37% of patients diagnosed with quiescent CD (8) and nearly a third of patients with UC in remission also reporting symptoms of IBS (8,9).”
Mikocka-Walus, A., Bampton, P., Hetzel, D., Hughes, P., Esterman, A., & Andrews, J. M. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9580-9 · Cited by 78 · cited 1×
“Though there is more evidence for CBT helping to decrease IBS symptoms, it is possible that CBT could also help with improving IBD symptoms, coping (18,19), health-related QOL [HRQoL; (26,27)], symptoms of depression or anxiety (18,26), catastrophizing (26), and visceral sensitivity (26).”
Hunt, M. G., Loftus, P., Accardo, M., Keenan, M., Cohen, L., & Osterman, M. T. (2019) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-019-09621-7 · Cited by 57
Lackner, J. M., Jaccard, J., Firth, R., Krasner, S., Hamilton, F., Keefer, L., Ma, C.-X., Radziwon, C., Sitrin, M., Brenner, D., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.10.033 · Cited by 45 · cited 1×
“While CBT for GI conditions can be effective, it may not be effective or be the best fit for all patients (51).”
Windgassen, S., Moss-Morris, R., Goldsmith, K., & Chalder, T. (2019) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2018.11.013 · Cited by 45 · cited 2×
“While CBT for non-GI conditions may focus on general cognitions and behaviors, research suggests that CBT for IBS is most effective when there is a focus on GI specific cognitions and anxiety (25).”
Cognitive Behavioral Therapy for IBS: How Useful, How Often, and How Does It Work?
Radziwon, C. D., & Lackner, J. M. (2017) · Current Gastroenterology Reports · doi:10.1007/s11894-017-0590-9 · Cited by 42
Carvalho, S. A., Skvarc, D., Barbosa, R., Tavares, T., Santos, D., & Trindade, I. A. (2022) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.2643 · Cited by 40
Naude, C., Skvarc, D., Knowles, S., Russell, L., Evans, S., & Mikocka-Walus, A. (2023) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2023.111232 · Cited by 37 · cited 1×
“Promisingly, other studies in IBS and IBD have examined components of ACT, like mindfulness (52-55) and found resulting success in reducing stress, improving HRQoL, or in some cases, reducing GI symptoms in these patient populations.”
Ferreira, N. B., Eugenicos, M. P., Morris, P. G., & Gillanders, D. T. (2013) · Quality of Life Research · doi:10.1007/s11136-012-0299-z · Cited by 33
Dober, M., Mikocka-Walus, A., Evans, S., Beswick, L., Emerson, C., & Olive, L. (2021) · Psychotherapy Research · doi:10.1080/10503307.2020.1813915 · Cited by 25 · cited 1×
“ACTforIBD was unique in that it specifically recruited patients with high levels of reported distress, involved a combination of therapist-led and self-guided sessions (44), and was developed in conjunction with patient stakeholders (45).”
Lavelle, J., Storan, D., Eswara Murthy, V., De Dominicis, N., Mulcahy, H. E., & McHugh, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102757 · Cited by 23
Sofia, M. A., Feuerstein, J. D., Narramore, L., Chachu, K. A., & Streett, S. E. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.01.050 · Cited by 21
An implementation trial of ACT-based bibliotherapy for irritable bowel syndrome
Gillanders, D., Ferreira, N. B., Angioni, E., Carvalho, S. A., & Eugenicos, M. P. (2017) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2017.04.006 · Cited by 21 · cited 9×
“Participants were instructed to complete the self-help manual at their own pace but were encouraged to complete the manual within two months (39).”
InfluentialTrindade, I. A., Pereira, J., Galhardo, A., Ferreira, N. B., Lucena-Santos, P., Carvalho, S. A., Oliveira, S., Skvarc, D., Rocha, B. S., Portela, F., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.699367 · Cited by 20 · cited 2×
“A third RCT, the Living with Intention, Fullness, and Engagement with Inflammatory Bowel Disease (LIFEwithIBD) trial, aimed to test the impact of an ACT intervention with compassion-based constructs (e.g., reductions in shame), as compared to treatment as usual (46,47).”
Romano, D., Chesterman, S., Fuller-Tyszkiewicz, M., Evans, S., Dober, M., Gearry, R., Gibson, P. R., Knowles, S., McCombie, A., O, E., et al. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad122 · Cited by 20 · cited 6×
“The intervention included eight online modules; the first three modules were led by a therapist, the following four were self-guided, and the last session was therapist-led (43,44).”
InfluentialHou, J. K., Vanga, R. R., Thakur, E., Gonzalez, I., Willis, D., & Dindo, L. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.05.022 · Cited by 17 · cited 3×
“Similarly, Hou and colleagues (49) asked participants with IBD to participate in a one-day (five hour) ACT program.”
Evans, S., Olive, L., Dober, M., Knowles, S., Fuller-Tyszkiewicz, M., O, E., Gibson, P., Raven, L., Gearry, R., McCombie, A., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-060272 · Cited by 15 · cited 3×
“ACTforIBD was unique in that it specifically recruited patients with high levels of reported distress, involved a combination of therapist-led and self-guided sessions (44), and was developed in conjunction with patient stakeholders (45).”
Petrik, M. L., Palmer, B. E., Khoruts, A., & Vaughn, B. P. (2021) · Crohn s & Colitis 360 · doi:10.1093/crocol/otab061 · Cited by 12 · cited 1×
“Given an overlap between patients with IBD also meeting criteria for IBS, it is plausible that symptoms in these patients could also improve with CBT (28).”
Trindade, I. A., Pereira, J. L., Galhardo, A., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.837357 · Cited by 2 · cited 1×
“A third RCT, the Living with Intention, Fullness, and Engagement with Inflammatory Bowel Disease (LIFEwithIBD) trial, aimed to test the impact of an ACT intervention with compassion-based constructs (e.g., reductions in shame), as compared to treatment as usual (46,47).”
Research works printed but not linked: 9
- [11]Survey highlights growing need for psychosocial support in IBD care amid high rates of anxiety and depression [press release]. American Gastroenterological Association, March 23, 2023. Available online: https://medicalxpress.com/news/2023-03-survey-highlights-psychosocial-ibd-high.html
- [21]Beck JS, Beck AT. Cognitive Behavior Therapy, Second Edition: Basics and Beyond. 2 ed. New York, USA: Guilford Publications; 2011.
- [30]Hayes SC, Strosahl K, Wilson KG. Acceptance and commitment therapy: An experiential approach to behavior change. 1 ed. New York: Guilford Press; 1999.
- [34]Kabat Zinn J. Mindfulness-based interventions in context: Past, present, and future. Clin Psychol 2003; 10: 144- 156.
- [36]Ferreira NB. Emerging approaches Acceptance and commitment therapy (ACT) approaches to gastrointestinal conditions. In: Knowles SR, Keefer L, Mikocka-Walus A, editors. Psychogastroenterology for Adults: A Handbook for Mental Health Professionals: Routledge; 2020. p. 254-65.
- [38]Ferreira NB Gillanders D Morris PG Pilot study of acceptance and commitment therapy for irritable bowel syndrome: A preliminary analysis of treatment outcomes and processes of change. Clinical Psychologist. 2018; 22: 241- 50. 10.1111/cp.12123 · DOI · Paper page
- [40]Ito M Muto T. Effectiveness of acceptance and commitment therapy for irritable bowel syndrome non-patients: A pilot randomized waiting list controlled trial. Journal of Contextual Behavioral Science 2020; 15: 85- 91. 10.1016/j.jcbs.2019.11.009 · DOI · Paper page
- [41]Bowers H Gillanders D Ferreira NB. Moderating effect of IBS acceptance on psychosocial mediators of irritable bowel syndrome. Journal of Contextual Behavioral Science 2020; 16: 30- 6. 10.1016/j.jcbs.2020.02.004 · DOI
- [62]Knowles S, Keefer L, Mikocka-Walus A. Psychogastroenterology for adults: A handbook for mental health professionals. 1 ed: Routledge; 2020. 328 p.
Cited by
Liu, H., Yang, G., & Wang, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010935 · Cited by 18
“…co-occur, with about 37% of patients diagnosed with quiescent Crohn’s disease and nearly a third of patients with ulcerative colitis in remission also reporting symptoms of IBS, and patients with IBS and IBD also commonly suffer from stress-related symptoms of anxiety and/or depression [95].”
BackgroundDigital and Conventional Behavioral Therapies for Neurogastroenterology and Motility Disorders
Dave, P. N., & Kinsinger, S. W. (2025) · Current Gastroenterology Reports · doi:10.1007/s11894-025-01007-0 · Cited by 2
Wang, H., Ding, J., Liu, G., Sun, G., Zhang, X., Xiao, W., Cai, Y., & Lin, A. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1630034 · Cited by 3
Eisele, M., Yousuf, M., Haskey, N., D’Silva, A., Nasser, Y., Franco, L., & Raman, M. (2025) · Neurogastroenterology & Motility · doi:10.1111/nmo.70179 · Cited by 1
“Finally, there is emerging literature for the efficacy of Acceptance and Commitment therapy (ACT) in IBS, a third-wave behavioral therapy whose principles are often incorporated in breathing and mindfulness practices [18, 19].”
Shah, A., Talley, N. J., Knowles, S. R., Duncanson, K., Koloski, N. A., Connor, J. P., Day, A. S., Almehdawy, B., Basnayake, C., Burgell, R., et al. (2026) · Neurogastroenterology & Motility · doi:10.1111/nmo.70337 · Cited by 2
“The specific Acceptance and Commitment Therapy approach that also utilizes components of mindfulness has some early evidence for reducing IBS symptoms and anxiety or depression, but efficacy data are currently limited [98, 99].”
Metadata
- Authors
- Marchese, S. H., Naftaly, J. P., & Pandolfino, J.
- Affiliations
- Northwestern University (US)
- University of Michigan (US)
- Corresponding author
- Marchese, Sara H.
- Venue
- Translational Gastroenterology and Hepatology
- Publisher
- AME Publishing Company
- Published
- 2024-07
- Volume
- 9
- Pages
- 43-43
- ISSN
- 2415-1289 (ISSN-L)
- PMC
- PMC11292080
- OpenAlex
- W4400567141
- Cited by
- 8
- References
- 47
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 1
- FWCI
- 0.53
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Translational Gastroenterology and Hepatology (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK092217)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- acceptance and commitment therapy, irritable bowel syndrome, inflammatory bowel disease, cognitive behavioral therapy, depression, anxiety, stress, quality of life, self-help intervention, mood symptoms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
